DIABETES MEDICATION UPDATE - PowerPoint PPT Presentation

About This Presentation
Title:

DIABETES MEDICATION UPDATE

Description:

A group of diseases characterized by inappropriate high blood sugar due to ... Inhaler and insulin blisters at room temperature in a dry place ... – PowerPoint PPT presentation

Number of Views:223
Avg rating:3.0/5.0
Slides: 29
Provided by: diabetesbi
Category:

less

Transcript and Presenter's Notes

Title: DIABETES MEDICATION UPDATE


1
DIABETESMEDICATION UPDATE
  • A. Sami Wood, MS, RD/LD,CDE
  • Center For Diabetes Education
  • OSUMC

2
What Is Diabetes?
  • A group of diseases characterized by
    inappropriate high blood sugar due to defects in
    the production and/or action of insulin and other
    hormones.

3
What is sugar doing in the blood?
  • Sugar is the bodys main source of energy
  • The body needs a constant supply of energy
  • Blood sugar is tightly controlled

4
Sources of Glucose in the Blood
  • Outside source food and drinks
  • Inside source liver

5
Insulin
  • A hormone made in the pancreas
  • Prevents blood sugar from going too high
  • - Allows the body to use sugar
  • - Allows the body to store extra sugar

6
Blood glucose and insulin
7
Normal Insulin/Glucose Patterns
8
Basal Insulin
  • Insulin required to control hepatic glucose
    output even when fasting.
  • Accounts for 50 of daily insulin needs.

9
Bolus Insulin
  • Insulin required to cover mealtime carbohydrates.
  • Accounts for the other 50 of insulin needs.

10
EXUBERA
  • An inhaled rapid-acting insulin for mealtime
    blood sugar control
  • Used in DM1 in combination with a basal insulin
  • Used in DM2 alone or in combination with a basal
    insulin and/or pills
  • Should be taken 0-10 minutes before a meal

11
  • A lung function test is required before a patient
    is started on Exubera and every 6 months
    thereafter

12
EXUBERA-Contraindications
  • Smokers
  • Patients with Asthma and COPD
  • Children
  • Pregnant women

13
EXUBERA
  • Store
  • Inhaler and insulin blisters at room temperature
    in a dry place
  • Unopened insulin blisters in their foil overlap

14
EXUBERA
  • Side effects
  • Hypoglycemia
  • Mild cough

15
WHAT ABOUT THE OTHER HORMONES INVOLVED IN
BLOOD SUGAR CONTROL?
16
Glucagon
  • A hormone made in the pancreas
  • Prevents blood sugar from going too low
  • - Allows the use of stored sugar
  • - Allows the production of new sugar in the
    liver

17
Amylin
  • A hormone made and released with insulin
  • Slows the flow of sugar from the stomach to the
    blood
  • Keeps the liver from making too much sugar
  • Helps us feel full

18
SYMLIN
  • An injectable hormone replacement for Amylin
  • Used in patients with DM1 or DM2 who are on
    insulin
  • Given immediately before major meals
  • May reduce needs for meal insulin or
    sulfonulureas by 50
  • Lasts in the body 3 hrs with peak action in 21 min

19
SYMLIN
  • Start low and go slow
  • Dose range 2.5 to 20 units
  • Store opened vials in the refrigerator or at room
    temperature for up to 28 days

20
SYMLIN
  • Side effects
  • Nausea
  • Hypoglycemia
  • Possible weight loss

21
SYMLIN
  • Not appropriate for patients with
  • Hypoglycemia unawareness
  • Gastroporesis or on meds affecting gastric
    motility
  • A1C gt9
  • Poor compliance with insulin shots

22
Incretins
  • Hormones made in the intestine in response to
    sugar in the blood.
  • Augment insulin secretion
  • Slow the flow of sugar from the stomach to the
    blood
  • Keep the liver from making too much sugar
  • Help us feel full

23
BYETTA
  • An analogue for one of the incretin hormones
    (GLP-1)
  • An injectable medicine
  • Used alone or in combination with metformin, TZD
    and/or sulfonylureas in patients with DM2.
  • Given 0-60 minutes before breakfast and supper

24
BYETTA
  • Available in 5 and 10 mcg pens
  • Opened pens are only good for 30 days.

25
BYETTA
  • Side effects
  • Nausea
  • Hypoglycemia especially when used with
    sulfonylureas
  • Possible weight loss

26
BYETTA
  • Not appropriate for patients with
  • Gastroporesis or on meds affecting gastric
    motility
  • A1C gt9
  • Severe liver or kidney disease

27
Galvus and Januvia
  • Galvus coming soon
  • Januvia available
  • Stabilize one of the incretins (GLP-1)
  • Used alone or in combination with metformin
    and/or TZD in patients with DM2.
  • A once a day pill.
  • No weight loss or gain observed.

28
  • More options for better diabetes management with
    more freedom and flexibility
Write a Comment
User Comments (0)
About PowerShow.com